Chronic Gastritis Clinical Trial
Official title:
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. in Korean Patients With Acute or Chronic Gastritis in Accordance With Korean Regulation, 'Standard for Re-examination of New Drugs'
This PMS is a non-interventional, prospective, single-arm, multi-center surveillance in accordance with Korean regulation, 'Standard for Re-Examination of New Drugs'. This PMS is to assess the safety and effectiveness after administrating Mucosta®SR Tab. Each subject would be observed for 2 weeks from baseline, if possible. As this PMS is an observational study in practical medical environment, the subject's follow-up is recommended but not obligatory and must be left up to the judgment of the investigator.
According to the "Standards for Re-examination of New Drugs, etc." of South Korea, this PMS is conducted in order to collect safety and efficacy information for patients prescribed with Mucosta®SR Tab. under actual conditions of treatment during the re-examination period of Mucosta®SR Tab. 150mg (Rebamipide) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04066530 -
A Study to Evaluate the Efficacy and Safety of AD-203
|
Phase 3 | |
| Completed |
NCT01817556 -
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
|
Phase 4 | |
| Recruiting |
NCT01813812 -
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
|
Phase 3 | |
| Completed |
NCT00996788 -
Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
|
Phase 3 | |
| Completed |
NCT04341454 -
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
|
Phase 3 | |
| Enrolling by invitation |
NCT05021029 -
A Study of Pre-Malignant Gastric Conditions
|
||
| Completed |
NCT05073614 -
Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis
|
N/A | |
| Completed |
NCT04697186 -
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
|
Phase 4 | |
| Recruiting |
NCT00455806 -
Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
|
Phase 3 | |
| Recruiting |
NCT05666531 -
Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously
|
||
| Completed |
NCT03847753 -
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions
|
||
| Completed |
NCT04189705 -
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
|
Phase 3 | |
| Completed |
NCT05014334 -
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
|
Phase 4 | |
| Completed |
NCT02356679 -
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
|
Phase 4 | |
| Completed |
NCT02219529 -
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases
|
Phase 3 | |
| Completed |
NCT03609892 -
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
|
Phase 4 | |
| Unknown status |
NCT02282670 -
A Study to Evaluate the Efficacy and Safety of DA-5204
|
Phase 3 | |
| Completed |
NCT01119768 -
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
|
Phase 4 | |
| Completed |
NCT02658864 -
Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets
|
Phase 1 |